Order Article Reprints

Guerrero-Vargas JM, Suarez-Garcia DA, Leal AF, Diaz-Ariza IL, Pérez-Pérez LD, Espejo-Mojica AJ, Alméciga-Díaz CJ. Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay–Sachs Disease. Pharmaceutics. 2025; 17(5):628. https://doi.org/10.3390/pharmaceutics17050628

Guerrero-Vargas, Jacky M., Diego A. Suarez-Garcia, Andrés F. Leal, Ivonne L. Diaz-Ariza, León D. Pérez-Pérez, Angela J. Espejo-Mojica, and Carlos J. Alméciga-Díaz. 2025. "Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay–Sachs Disease" Pharmaceutics 17, no. 5: 628. https://doi.org/10.3390/pharmaceutics17050628

Guerrero-Vargas, J. M., Suarez-Garcia, D. A., Leal, A. F., Diaz-Ariza, I. L., Pérez-Pérez, L. D., Espejo-Mojica, A. J., & Alméciga-Díaz, C. J. (2025). Evaluation of the PP6D5 Polymer as a Novel Non-Viral Vector in the Development of a CRISPR/nCas9-Based Gene Therapy for Tay–Sachs Disease. Pharmaceutics, 17(5), 628. https://doi.org/10.3390/pharmaceutics17050628